U.S. Federal Trade Commission:
* Approved final order settling charges that DaVita Inc’s acquisition of Renal Ventures Management would have been anticompetitive Source text: (bit.ly/2sag5GV) Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)